Key facts
- Canada is the first G7 country to approve a generic version of Ozempic.
- The lower-cost weight-loss drug is rolling out in Canadian pharmacies this month.
Canada has become the first G7 country to approve a lower-cost generic version of the popular weight-loss drug Ozempic. The rollout of this generic version is commencing in Canadian pharmacies this month, offering a more affordable alternative to the branded medication. This development highlights a divergence in drug pricing and access policies between Canada and the United States.